Singapore markets closed

Straits Times Index
3,307.90
-6.15(-0.19%)
Nikkei
38,617.10
-329.83(-0.85%)
Hang Seng
19,195.60
-25.02(-0.13%)
FTSE 100
8,360.59
-55.86(-0.66%)
Bitcoin USD
69,755.48
-1,405.75(-1.98%)
CMC Crypto 200
1,502.90
-23.52(-1.54%)

Co-Diagnostics, Inc. (CODX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.1000

0.0000

(0.00%)

At close: 04:00PM EDT

1.1200

+0.02

(+1.82%)

After hours:

05:28PM EDT

Trade prices are not sourced from all markets

All

Simply Wall St.
Co-Diagnostics First Quarter 2024 Earnings: Misses Expectations
Co-Diagnostics ( NASDAQ:CODX ) First Quarter 2024 Results Key Financial Results Net loss: US$9.31m (loss widened by 62...
Insider Monkey
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript May 9, 2024 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31204 EPS, expectations were $-0.21. CODX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
PR Newswire
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results
Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2024.